FAST-Funded Research Leads To $1.1 Million Grant
Additional Gene Therapy Approach For Angelman Syndrome Explored By Paula Evans The Foundation for Angelman Syndrome Therapeutics (FAST) is delighted to annou
Towards Therapeutics – The FIRE Team Series, Part I
Edwin Weeber, Ph.D. is a Professor in the Department of Molecular Pharmacology and Physiology and the Chief Scientific Officer at the University of South Flo
Ketone esters for the treatment of seizures in AS – clinical trial coming soon!
Medical foods as an effective approach to management of Angelman Syndrome The following is a recount of a presentation about using therapeutic ketones (KES)
FAST Research Series
Read our regular series summarizing lectures presented on Friday December 4th, 2015, the first day of the 2015 FAST Global Summit. This series will be focuse
Behind the Scenes ~ Science Director, Allyson Berent
Please join us in welcoming Allyson Berent to the position of Science Director on the Foundation for Angelman Syndrome Therapeutics (FAST) Board of Dire
Community Nominates FAST for Chase Giving Contest
Great news!!!! The Angelman community has nominated the Foundation for Angelman Syndrome Therapeutics (FAST) to be a part of the 2012 Chase Community Givin